Zobrazeno 1 - 10
of 19
pro vyhledávání: '"K A Thursky"'
Autor:
A Khanina, A P Douglas, D K Yeoh, M So, J Abbotsford, T Spelman, D C M Kong, M A Slavin, K A Thursky
Publikováno v:
Journal of Antimicrobial Chemotherapy. 78:1367-1377
Background The Antifungal National Antimicrobial Prescribing Survey (AF-NAPS) was developed to undertake streamlined quality audits of antifungal prescribing. The validity and reliability of such tools is not characterized. Objectives To assess the v
Autor:
O C, Smibert, M A, Slavin, B, Teh, A G, Heriot, J, Penno, H, Ismail, K A, Thursky, L J, Worth
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 28(6)
CRS-HIPEC is associated with improved cancer survival but an increased risk of infection.Consecutive patients undergoing CRS-HIPEC between January 2016 and May 2018 were retrospectively reviewed. Malignancy type, comorbidities, perioperative risk fac
Publikováno v:
Internal medicine journal. 46(10)
Identifying themes associated with inappropriate prescribing in Australian public and private hospitals will help target future antimicrobial stewardship initiatives.To describe current antimicrobial prescribing practices, identify similarities and d
Autor:
C C, Blyth, N M, Gilroy, S D, Guy, S T, Chambers, E Y, Cheong, T, Gottlieb, S L, McGuinness, K A, Thursky
Publikováno v:
Internal medicine journal. 44(12b)
Mould species represent the pathogens most commonly associated with invasive fungal disease in patients with haematological malignancies and patients of haemopoietic stem cell transplants. Invasive mould infections in these patient populations, parti
Publikováno v:
Internal medicine journal. 44(12b)
Pneumocystis jirovecii infection (PJP) is a common cause of pneumonia in patients with cancer-related immunosuppression. There are well-defined patients who are at risk of PJP due to the status of their underlying malignancy, treatment-related immuno
Autor:
M A, Slavin, K A, Thursky, L J, Worth, C C, Chang, C O, Morrissey, C C, Blyth, S C, Chen, J, Szer
Publikováno v:
Internal medicine journal. 44(12b)
This article introduces the second revision of the Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting. The current update occurs within the context of a growing population at risk of i
Autor:
S J, van Hal, N M, Gilroy, C O, Morrissey, L J, Worth, J, Szer, C S, Tam, S C, Chen, K A, Thursky, M A, Slavin
Publikováno v:
Internal medicine journal. 44(12b)
This article reports the findings of a survey developed to assess the current use of antifungal prophylaxis among haematology and infectious disease clinicians across Australia and New Zealand, and their alignment with existing consensus guidelines f
Autor:
S, Lingaratnam, A, Mellerick, L J, Worth, M, Green, S, Guy, S, Kirsa, M, Slavin, W, Renwick, R, Filshie, K A, Thursky
Publikováno v:
Internal medicine journal. 43(9)
Although Australian consensus guidelines support the use of ambulatory care strategies for management of adult patients with low-risk neutropenic fever (NF), few centres have successfully implemented viable programmes.To study the feasibility of an e
Publikováno v:
Internal medicine journal. 41(10)
Legionella species are a common cause of community-acquired pneumonia, infrequently complicated by cavitary disease. We describe Legionella pneumophila pneumonia and abscess formation in an immunosuppressed patient receiving corticosteroid therapy fo
Publikováno v:
Internal medicine journal. 42(2)
FDG-PET/CT is widely used in the management of a variety of malignancies with excellent overall accuracy, despite the potential for false positive results related to infection and inflammation. As cancer patients can develop clinically inapparent inf